138 related articles for article (PubMed ID: 34274801)
1. Early risk-assessment of patients with nasopharyngeal carcinoma: the added prognostic value of MR-based radiomics.
Kim MJ; Choi Y; Sung YE; Lee YS; Kim YS; Ahn KJ; Kim MS
Transl Oncol; 2021 Oct; 14(10):101180. PubMed ID: 34274801
[TBL] [Abstract][Full Text] [Related]
2. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models.
Choi Y; Nam Y; Jang J; Shin NY; Lee YS; Ahn KJ; Kim BS; Park JS; Jeon SS; Hong YG
Eur Radiol; 2021 Apr; 31(4):2084-2093. PubMed ID: 33006658
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive integrated analysis of MR and DCE-MR radiomics models for prognostic prediction in nasopharyngeal carcinoma.
Li H; Huang W; Wang S; Balasubramanian PS; Wu G; Fang M; Xie X; Zhang J; Dong D; Tian J; Chen F
Vis Comput Ind Biomed Art; 2023 Dec; 6(1):23. PubMed ID: 38036750
[TBL] [Abstract][Full Text] [Related]
4. MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy.
Siow TY; Yeh CH; Lin G; Lin CY; Wang HM; Liao CT; Toh CH; Chan SC; Lin CP; Ng SH
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551604
[TBL] [Abstract][Full Text] [Related]
5. Differences in Radiomics Signatures Between Patients with Early and Advanced T-Stage Nasopharyngeal Carcinoma Facilitate Prognostication.
Wu S; Li H; Dong A; Tian L; Ruan G; Liu L; Shao Y
J Magn Reson Imaging; 2021 Sep; 54(3):854-865. PubMed ID: 33830573
[TBL] [Abstract][Full Text] [Related]
6. Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma.
Shen H; Wang Y; Liu D; Lv R; Huang Y; Peng C; Jiang S; Wang Y; He Y; Lan X; Huang H; Sun J; Zhang J
Front Oncol; 2020; 10():618. PubMed ID: 32477932
[No Abstract] [Full Text] [Related]
7. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
8. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
[TBL] [Abstract][Full Text] [Related]
9. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
[No Abstract] [Full Text] [Related]
10. Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma.
Kulanthaivelu R; Kohan A; Hinzpeter R; Liu ZA; Hope A; Huang SH; Waldron J; O'Sullivan B; Ortega C; Metser U; Veit-Haibach P
Front Oncol; 2022; 12():952763. PubMed ID: 36353565
[TBL] [Abstract][Full Text] [Related]
11. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
[TBL] [Abstract][Full Text] [Related]
12. Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics.
Zhang B; Ouyang F; Gu D; Dong Y; Zhang L; Mo X; Huang W; Zhang S
Oncotarget; 2017 Sep; 8(42):72457-72465. PubMed ID: 29069802
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma.
Bao D; Zhao Y; Liu Z; Zhong H; Geng Y; Lin M; Li L; Zhao X; Luo D
Discov Oncol; 2021; 12(1):63. PubMed ID: 34993528
[TBL] [Abstract][Full Text] [Related]
14. Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment.
Bao D; Liu Z; Geng Y; Li L; Xu H; Zhang Y; Hu L; Zhao X; Zhao Y; Luo D
Cancer Imaging; 2022 Jan; 22(1):10. PubMed ID: 35090572
[TBL] [Abstract][Full Text] [Related]
15. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for the prediction of progression-free survival in advanced nasopharyngeal carcinoma.
Li WZ; Wu G; Li TS; Dai GM; Liao YT; Yang QY; Chen F; Huang WY
Front Oncol; 2022; 12():955866. PubMed ID: 36338711
[TBL] [Abstract][Full Text] [Related]
17. A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0.
Zhong LZ; Fang XL; Dong D; Peng H; Fang MJ; Huang CL; He BX; Lin L; Ma J; Tang LL; Tian J
Radiother Oncol; 2020 Oct; 151():1-9. PubMed ID: 32634460
[TBL] [Abstract][Full Text] [Related]
18. Integration of MRI-Based Radiomics Features, Clinicopathological Characteristics, and Blood Parameters: A Nomogram Model for Predicting Clinical Outcome in Nasopharyngeal Carcinoma.
Fang ZY; Li KZ; Yang M; Che YR; Luo LP; Wu ZF; Gao MQ; Wu C; Luo C; Lai X; Zhang YY; Wang M; Xu Z; Li SM; Liu JK; Zhou P; Wang WD
Front Oncol; 2022; 12():815952. PubMed ID: 35311119
[TBL] [Abstract][Full Text] [Related]
19. Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients.
Bologna M; Corino V; Calareso G; Tenconi C; Alfieri S; Iacovelli NA; Cavallo A; Cavalieri S; Locati L; Bossi P; Romanello DA; Ingargiola R; Rancati T; Pignoli E; Sdao S; Pecorilla M; Facchinetti N; Trama A; Licitra L; Mainardi L; Orlandi E
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066161
[TBL] [Abstract][Full Text] [Related]
20. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
